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Summary 
Past work has shown that a subset of effector T cells with unique characteristics could abrogate 
hapten- or antigen-induced tolerance, and the reconstitution of this immune response has been 
termed contrasuppression. Wehave studied contrasuppression n amodel of oral tolerance (OT) 
in which adoptively transferred antigen-specific T contrasuppressor (Tcs) cells reverse OT and 
result in antibody responses to the eliciting antigen. In the present study, we show that murine 
intraepitbelial lymphocytes (IELs) from mice orally immunized with sheep red blood cells (SRBC) 
contain T cells that exhibit Tcs cell activity. This effect was mediated by CD3 + 346 T cell 
receptor-positive (TCR+), but not ~//3 TCR + T cells, and "y/~ TCR + Tcs cells were associated 
with both the CD4-,CD8 + and CD4-,CDS- (double-negative) IEL fractions. The 
CD4-,CD8 + "y/6 TCR + IELs were further separated into Vicia villosa-adherent and 
-nonadherent fractions. Adoptive transfer of V. villosa-adherent "y/~ TCR + T cells to mice with 
OT to SRBC resulted in splenic IgA, IgM, and IgG subclass anti-SRBC responses, while V. 
villosa-nonadherent "y/tf TCR + T cells were without activity. The 3'/6 TCR + IELs did not 
support in vitro antibody responses in B cell cultures, while od3 TCR + IELs were effective 
T helper cells. Further, cytokine production by the 3//6 TCR + IELs was examined, and the 
3'/6 TCR + V. villosa-adherent fraction, which possessed contrasuppressor function, contained 
low levels of I1:5 mRNA and small numbers of I1:5-producing cells when compared with oe/3 
TCR + IELs and V. villosa-nonadherent "y/~ TCR + IELs. Our results now show that mouse 
IELs contain two distinct types of T cells that function in the immune response, e.g., or//3 
TCR + T cells that produce I1:5 and function as helper cells, and 3'/6 TCR + T cells that restore 
antibody responses in mice that had been orally tolerized with antigen. 
n important feature of the mucosal immune system in 
the gastrointestinal (GI)* tract is the distinct lymphoid 
aggregates, the Peyer's patches (PP), which are major IgA 
inductive sites. These differ from the effector regions, which 
include the lamina propria, where large numbers of CD4 + 
T cells and IgA-producing plasma cells are present (reviewed 
in reference 1). Less well understood effector sites include the 
1 Abbreviations used in this Imper: DN, double negative; DP, double positive; 
ELISPOT, Enzyme-linked immunospot; GI, gastrointestinal; IEL, 
intraepithelial lymphocyte; OT, oral tolerance; PFC, plaque-forming cell; 
PP, Peyer's patch; SFC, spot-forming cell; Tcs, T contrasuppressor. 
lymphocyte population, which resides in the epithelial layer, 
and the intraepithelial lymphocytes (IELs), which first en- 
counter the myriad of antigens that are present in the GI 
tract. It is important o better understand the function of 
lymphocytes in these effector regions, since >101~ Ig- 
producing cells occur per meter of human intestine and one 
of every six cells in the epithelium is an IEL (1, 2). These 
IELs possess a number of unique features that are distinct 
from lymphocytes residing in other lymphoid tissues, including 
their phenotype ofsurface markers, use of heterodimeric chains 
of TCR, and biologic functions. 
Generally, 80-90% of mononudear cells isolated from the 
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mouse intestinal epithelium express CD3 and an associated 
TCR, and '~75% of these are CD4-,CD8 + (3, 4). Other 
subsets include CD4§ + (double positive; DP), 
CD4 + ,CD8- and CD4-,CD8- (double negative; DN) in 
approximately equal frequencies (5, 6). In mice, a high fre- 
quency of CD3 + IELs use the TCR composed of a "y chain 
disulfide linked to the 6 chain (3'/~ TCR) (3, 4). Thus, the 
present study and the work of others have shown that 45-65% 
of CD4-,CD8 + IELs use the "y/~ TCR, while 35-55% of 
this subset express ~/B TCR (7, 8). The IEL compartment 
contains asubpopulation ofT cells that develop in the intes- 
tinal epithelium itself without thymic influence (9-11). 
Specifically, the 3,//~ TCR-bearing T cells in IELs have been 
shown to be of extrathymic origin (9, 10). Further, more 
recent work has shown that these CD8 + 3'/~ TCR + IELs 
express the homodimeric form (or/or) of the CD8 molecule, 
are derived from bone marrow, and are distinct from a sub- 
population of c~/B TCR + T cells in IELs. In this regard, 
ot/~ TCR + IELs express heterodimeric c~/B CD8 chains, 
are of thymic origin, and are recent emigrants from the PP 
(11). In addition, the DN subset, representing ,,08% of 
CD3 + IELs, exclusively use the 3'/6 TCR, while DP and 
CD4 + ,CD8- IELs only express the ot/B TCR (8). Recent 
studies have shown that the TCR + T cells in IELs are en- 
coded by the Vv7 and V~I (or V64) genes, which are distinct 
from the 3'/~ TCR+ cells in other tissues (3, 4, 7, 12). Most 
studies to date have associated IELs with cytotoxic functions, 
in part due to their predominant expression of CD8 (13). 
In this regard, IELs with cytotoxic activity were induced both 
in vivo and in vitro by immunization with allogeneic an- 
tigens (14-16). Further, IELs contain subsets with natural 
killer function and spontaneous cytotoxic activity (17, 18). 
Based upon immune, physiologic, and anatomical considera- 
tions, the IELs are continuously exposed to environmental 
antigens from the gut lumen but also are present above the 
lamina propria regions, where large numbers of plasma cells 
produce Igs, largely of the IgA isotype (1). Thus, IELs are 
in sentinel ocations to potentially serve as regulatory cells 
for mucosal immune responses. 
Our studies have focused on immunoregulatory functions 
for both c~/B TCR + and 3'/~ TCR + T cells in IELs. We 
have used a model that determines the ability of different T 
cell subsets to abrogate a state of systemic unresponsiveness, 
termed oral tolerance (OT), which is induced by the repeated 
oral administration ofT-dependent antigens. Thus, adoptive 
transfer of antigen-specific T contrasuppressor (Tcs) cells to 
recipients, rendered tolerant o the same antigen, results in 
restoration of systemic antibody responses (6, 19-23). In the 
present study, we have directly isolated the y/~ TCR § T 
cells from both CD4-,CD8 § and DN IEL subsets of mice 
orally immunized with SRBC and compared them with cr 
TCR + IELs for their regulatory functions in abrogation of 
OT and for help in in vitro antibody responses. Our results 
are discussed from the standpoint that IEL T cells function 
in the immune response. Further, 3~/~ TCR + IEL T cells 
exhibit an important potential for the maintenance ofappro- 
priate mucosal antibody responses in the presence of OT and 
mediate these antigen-specific regulatory functions in mucosal 
effector regions where antigens are normally encountered from 
the environment. 
Materials and Methods 
M~ C3H/HeN mice were obtained from the Frederick.Cancer 
Research Facility (National Cancer Institute, Frederick, MD) and 
were maintained in horizontal flow cabinets and provided sterile 
food and water ad libitum. All mice used in this study were be- 
tween 8 and 12 wk of age. 
Induction and Abrogation of Oral Tolerance. SRBC or horse 
(H)RBC (Colorado Serum Co., Denver, CO) were washed in HBSS 
and resuspended to50% in eight parts HBSS and two parts so- 
dium bicarbonate (6, 19-23). Mice were orally tolerized by the ad- 
ministration of this suspension (0.25 ml) daily via gastric intuba- 
tion for 28 consecutive days (6, 19-23). To study immunoregulatory 
functions of IELs, mice were orally primed with SRBC or HRBC 
by daily gastric intubation for three consecutive days (6, 21). In 
some studies, T ceils were isolated from IELs of mice orally im- 
munized with SRBC for 28 d. As controls, T cells were obtained 
from spleens of mice orally immunized with SRBC for 3 or 28 d. 
1 wk later, mice were killed and different subsets of IELs were ob- 
tained as described below. Individual IEL T cell fractions (5 x 104 
to 1 x 104 ceils) were adoptively transferred intravenously to mice 
that had been orally tolerized with SRBC (6, 19-23). These mice 
were then immunized by the intraperitoneal injection of 0.1 ml 
of a 20% suspension of SRBC. After 4 d, the mice were killed, 
their spleens removed, and the number and isotype of the anti- 
SRBC plaque forming cells (PFC) determined as described below. 
Isolation oflELs and Spleen Cells. IELs were isolated by a pro- 
tocol described previously (6, 8, 24). Briefly, the small intestines 
were obtained from four to five mice and the mesenteric lymph 
nodes, connective tissues, and PP were carefully removed. The in- 
testines were then opened longitudinally, cut into short segments 
(,'~1 cm), and washed extensively in RPMI 1640 containing so- 
dium bicarbonate, nonessential mino acids, sodium pyruvate, 
L-glutamine, penicillin, streptomycin, and gentamicin (incomplete 
medium) containing 2% FCS (6, 8, 24). To obtain the IELs, the 
tissue was first incubated inincomplete medium for 30 min at 37~ 
with stirring, and then transferred to a 50-ml centrifuge tube, shaken 
vi~6rously for 15 s, and the medium containing cells was removed. 
This process was repeated two additional times. The harvested cells 
were pooled, washed, resuspended in incomplete medium containing 
5% FCS, and then passed through a small column of cotton and 
loosely packed glass wool to remove dead cells and tissue debris. 
Discontinuous density gradients were prepared using Percoll (Phar- 
macia Fine Chemicals, Uppsala, Sweden), in 15-ml centrifuge tubes 
by layering from the bottom 75% (2 ml) and then 40% (2 ml) 
Percoll. Approximately 3-4 x 107 cells in 3 ml medium were 
layered onto the gradient and centrifuged at 25~ for 20 min at 
600 g. The interface between the 75% and 40% layers contained 
lymphocytes with a cell viability of>95%. Approximately 5-7 x 
106 lymphocytes/mouse w re obtained from these gradients. 
Spleens were aseptically removed and single cell suspensions were 
prepared by gently teasing these tissues through sterile stainless 
steel screens into incomplete medium. Clumps were removed by 
settling at 1 g, and the cell-rich supernatant was removed, washed 
in incomplete medium, and resuspended in appropriate medium 
(6, 8, 19-24). 
Purification of lEL T Cell Subsets by Magnetic-activated C llSorting 
(MACS) and FACS | IELs were resuspended in warm (37~ in- 
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complete medium with 5% FCS and washed four times in this 
medium. To remove adherent cells, the washed cells were re- 
suspended to 5 x 106 ceUs/ml, added to tissue culture plates, and 
incubated for 3 h at 37~ The nonadherent cells were :>99% viable, 
and purified CD3 + or CD8 + T cells were obtained with the 
MACS system (Stefan Miltenyi Biotec GmbH, Mortzfeld Bergisch- 
Gladbach, Germany) by using anti-CD3 mAb (145-2Cll; 25) or 
anti-CD8 antibody (53.6-72; 26) (6, 8, 24). This procedure sulted 
in a preparation containing >99% viable CD3 + T cells. For the 
isolation of3'/(5 TCK + or cr TCK + T cells, the CD3 + cell frac- 
tion was incubated with FITC-conjugated anti-3'/(5 TCK (UC7- 
13D5; 27) and biotinylated anti-cffl3 TCK (H57-597; 28) mAbs 
fonowed by avidin-PE and then subjected to FACS | sorting 
(FACStarVh~; Becton Dickinson & Co., Sunnyvale, CA). In some 
experiments, CD3 + IELs were incubated with biotinylated anti- 
CD8 (53.6-72; 26) and with FITC-anti-3,/(5 TCK (UC7-13D5; 27) 
or FITC-anti-ot//3 TCR (H57-597; 28) n-tAbs followed by avidin- 
PE to obtain the CD3+,CD8 + 3,/8 TCK + or CD3+,CD8 + o.//3 
TCK + cell subsets. To obtain CD3 + DN T cells, IELs were 
reacted with FITC-anti-CD3 (145-2Cll; 25) and arsanilic acid 
(AKS)-conjugated anti-CD4 (GK 1.5; 29) and AKS-anti-CD8 (53.6- 
72; 26) mAbs followed by PE-conjugated anti-AKS before FACS | 
sorting. These cells were then incubated with hiotinylated anti- 
3,/(5 TCK (UC7-13D5; 27) or anti-od/$ TCK (H57-597; 28) mAbs 
followed by an avidin-PE-Texas red tandem (avidin-tandem) to de- 
termine the nature of the TCR on CD3 + DN IELs. Further, an 
aliquot of CD3 + ,CD8 + T cells were stained with FITC-anti-3,/(5 
TCK (UC7-13D5; 27) and biotinylated Vicia viUosa lectin (E. Y. 
Laboratories, San Mateo, CA) followed by avidin-PE and then sub- 
jected to cell sorting by using a FACStar m'| These FACS | sepa- 
rations allowed a purity of >99% for each of the IEL T cell subsets. 
In Vitro Immune Responses. Spleen cells were prepared from mice 
orally tohrized with SRBC. Spleen cells were resuspended in com- 
plete MEM (Gibco Laboratories, Grand Island, NY) containing 
2-ME (5 x 10 -s M) (20-22). The cells were cultured (5 x 
106/0.5 ml/well) in 24-well macroculture plates (Linbro Chem- 
ical Co., Hamden, CT) either in the presence or absence of murine 
rlL-5 (5 U/ml; 30, 31) and were immunized with SRBC (2 x 
106/well). In addition, some wells containing spleen cells from 
mice rendered orally tolerant o SKBC received 3,/(5 TCR + IEL 
T cells (5 x 104/well) isolated from mice orally primed with 
SRBC (20-22) (see above). In some experiments, splenic B cell cul- 
tures were prepared from normal mice for the assessment of Th 
cell function. Spleens were removed from mice that had received 
0.1 ml of undihted goat anti-thymocyte serum (Calbiochem-Behring 
Co., La Jolla, CA) by intravenous injection 2 d previously (31). 
Single spleen cells were then treated with a monodonal nti-T cell 
cocktail consisting of anti-CD4 (GK1.5; 29), anti-CD8 (53.6-72; 
26), and anti-Thy-l.2 (30-H12; 26) for 30 min at 4~ followed by 
incubation with monoclonal nti-rat K chain (MAR 18.5; 32), then 
incubated for 30 min at 37~ with a 1/10 diluted baby rabbit com- 
plement (Pel-Freeze Biologicals, Rogers, AK) (31). Cells obtained 
by this procedure were >96% slg + (31). Different subsets of T 
cells (1-2 x 106/well) were then added to individual B cell cul- 
tures (5 x 106 cells) containing SRBC (1-2 x 106 cells/well). 
These cultures were incubated for 5 d at 37~ in an atmosphere 
of 7% 05, 10% COs, and 83% N2 (20-22). Nonadherent cells 
were removed from in vitro cultures and the number, and isotype 
of the anti-SRBC PFC were determined as described below. 
PFC Assay. Single cell suspensions from the spleens of im- 
munized mice or in vitro cultures were washed and resuspended 
in HBSS before assay. Spleen cell suspensions were assayed in tripli- 
cate for IgM, IgG1, IgG2b, and IgA anti-SRBC or -HRBC PFC 
responses using the modified Jeme-Nordin slide method as previ- 
ously described (6, 19-23). Our past studies have shown that no 
SRBC-specific IgG2a or IgG3 subclass responses occur in this adop- 
tive transfer system (6, 19-23). 
Enumeration of Cytokine-producing Cells by Enzyme-linked Im- 
munospot (ELISPOT) Assay. For the quantitation of IFN-3,- or 
IbS-producing ceils in IELs, the cytokine-specific ELISPOT assay 
was used (8, 24). In this assay, a96-well plate with a nitrocellulose 
base (Millititer HA; Millipore Corp., Bedford, MA) was coated 
with mAb anti-IFN-3" (R4-6A2; 33) and/or anti-Ib5 (TRFK-5; 
34), as previously described (8, 24). Different subsets of IELs (103 
to 10 s cells/well) in complete medium (incomplete medium con- 
taining 10% FCS) were added to individual wells. After incuba- 
tion for 20 h, the plates were washed and then incubated with 
biotinylated mAb anti-IFN-3, (XMG 1.2; 35) or biotin-anti-IL-5 
(TRFK-4; 34) followed by avidin-peroxidase and the substrate 
3-amino-9-ethyl-carbazole. Th  spots were counted with the aide 
of a dissecting microscope. To estimate the frequency of T ceils 
that produce ither IFN-3' or Ib5 or both (termed ouble cytokine 
producers), nitrocellulose plates were coated with both TKFK-5 
(34) and R4-6A2 (33). Different subsets of IELs were added and 
spot-forming cells (SFC) developed with either biotinyhted TRFK-4 
(34) or XMG 1.2 (35), or with both antibodies together (24). The 
percentage of double producer cells was calculated from the fol- 
lowing formula (24): 100x [(total calcuhted - actual total)/(actual 
total)]; where total calculated = the SFC enumerated by anti- 
IFN-3, only plus the SFC enumerated byanti-IL-5 only, and actual 
total = the SFC enumerated by both anti-IFN-3' and anti-Ib5. 
Cycloheximide treatment ofT cells reduced by 85-90% the numbers 
of cytokine-specific SFC, clearly showing the de novo synthesis of 
these cytokines. 
mRNA-cDNA Dot Blot Analysis. The cDNA probe for mu- 
rine IFN-3" (Clontech Laboratories, Inc., Palo Alto, CA) was used 
according to the conditions recommended by the suppliers. The 
cDNA for the IL-5 PstI fragment was also used in this study (36) 
and the IL-5 cDNA was isolated from Escherichia coli transformed 
with the plasmid peD-SRa-5 as described (37). Standard mKNA- 
cDNA dot blot hybridization was used (8, 38). Briefly, subsets of 
purified IELs were lysed by NP-40 (5%) buffer. After removal of 
cen nuclei and debris by centrifugation, the supematants were mixed 
with SSC buffer in the presence of 7.5% formaldehyde and incubated 
for 15 min at 65~ An appropriate dilution range of mKNA was 
dotted and immobilized on nitrocellulose paper using a Manifold | 
device (Schleicher & Schuell, Inc., Dassd, Germany). Pre- and ac- 
tual hybridization of filters were performed as described by others 
(39). The 3~P-labeled denatured cDNA was added and incubated 
at 42~ for 24-48 h. Filters were washed with 2x SSC followed 
by 0.1x SSC buffer containing SDS and were then exposed to x-ray 
films using an intensifier screen. Developed films were scanned using 
a scanner (Apple Computer, Inc., Cupertino, CA) to quantitate 
the level of hybridization. To insure the quality of mRNA isolated 
from IELs, the same filters were hybridized with an actin-specific 
cDNA probe. 
Statistics. The results of PFC and SFC responses were expressed 
as the mean _+ SD. The significance of the difference in means 
was determined by the student's t test. 
Results 
7/r TCR § IELs Abrogate Oral Tolerance. To directly test 
whether 3'/8 TCR-bearing T cells in IELs possess an im- 
munoregulatory function (e.g., contrasuppression), purified 
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CD3 + IELs from mice orally primed with SRBC for 3 d 
were separated into 3,//5 TCK + and oe//~ TCK + fractions 
by FACS | using the anti-3,/8 TCK (UCT-13DS) and anti- 
oe//~ TCt((H57-597) mAbs. The FACS | profile revealed two 
distinct nonoverlapping populations of CD3 + ~//8 TCP, + 
and c~/fl TCK + T ceU subsets in IELs (Fig. 1 A). Thus, ac- 
cording to the FACS | profile, 100% pure "y/8 TCR + or 
od/3 TCK + T cells were separated and used in this experi- 
ment. When purified CD3 + T/8 TCK + or c~/fl TCK + T 
calls were adoptively transferred to mice orally tolerized with 
SP, BC, conversion of OT to IgM, IgG1, IgG2b, and IgA 
responses was only seen in mice that received 3'/8 TCP- + 
cells and the homologous antigen (Fig. 1 B). On the other 
hand, the c~//~ TCK + T call fraction did not abrogate OT. 
These results are the first direct proof that T cells that use 
the "y/8 TCP, function in antigen-specific immunoregulation, 
e.g., these T cells mediate contrasuppression. Further, ~'/~ 
TCK + T cells isolated from IELs of mice orally immunized 
with SILSC for 28 d also abrogate OT (see bdow). To en- 
sure the antigen specificity of Tcs cells in IELs, CD3 + T 
cells isolated from mice orally primed with either SRBC or 
HR.SC were adoptively transferred to mice that were orally 
tolerant o SR.BC. Abrogation of OT to SILBC-spedfic im- 
mune responses was ouly achieved by the transfer of CD3 + 
T cells from SR.BC-primed mice, but not from mice that 
were primed with HP..BC (Fig. 1 B). Further, CD3 + 3:/8 
TCK + IELs from normal mice did not abrogate OT. These 
findings confirmed our previous observations that Tcs cells, 
which abrogate OT, possess antigen-specificity (6, 18-20). 
Both CD4-,CD8 + and DN "f/~ TCR + T Cell Subsets 
Possess Contrasuppressor Function. Based on the studies of others 
and our own work (6-8), 348 TCK + T cells are associated 
with the CD4-,CD8 + and DN IEL fractions. Thus, 
CD4-,CD8 + ~//8 TCK + or DN "y/8 TCK + IELs were iso- 
lated from SP,.SC orally primed and normal mice, and their 
ability to abrogate OT was emanined (Fig. 2, A and B). When 
CD3 + ,CD8 + IELs were stained for ")'//5 TCK expression, 
45-65% of the •4 x 106 CD3+,CD8 + IEL T cells (per 
mouse) were "y/8 TCK + , while 35-55% were od/~ TCR + 
(Fig. 2 A,/eft). When the converse xperiment was performed 
by using mAb anti-'y/8 TCK, 35-55% of CD3+,CD8 + 
IELs were cx/:/TCK + (Fig. 2 A, right), while the remaining 
45-65% of CD3 +,CD8 + IELs did not express this receptor. 
FACS | analysis of CD3 +, DN IELs from SR.BC orally 
primed and normal mice revealed that 100% of the cells were 
"y/8 TCK + (Fig. 2 B). This fraction represents ,,08% of 
"~5.5 x 10 ~ IEL CD3 + T cells per mouse. "y/8 TCtL + cells 
were not found in the CD4+,CD8 - and DP fractions; how- 
ever, these cells did express od/~ TCK (data not shown). These 
results howed that "y/8 TCK + T cells are only found in the 
CD4-,CD8 + and DN fractions of the IELs from SR.BC 
orally primed and normal mice (7, 8). 
When these subsets of "),/8 TCK + IELs were examined 
for contrasuppressor activity, the CD3 + ,CD8 + 3'/8 TCR. + 
T cell fraction converted OT to IgM, IgG1, IgG2b, and IgA 
anti-SgBC PFC responses upon adoptive transfer (Fig. 2 C). 
In contrast, the CD8 + o~/fl TCK + T cell fraction did not 
reverse OT to SILBC-specific immune responses. In addition, 
the adoptive transfer of 'y/8 TCP, +, DN T cells in IELs 
from SP,.BC orally primed mice also resulted in conversion 
Figure 1. CD3 § ~//8 TCR + IELs from SRBC orally primed mice abrogate OT to antigen-specific IgM, IgG1, IgG2b, and IgA responses. Purified 
CD3 + IELs were incubated with FITC-anti-3,/6 TCR (UC7-13D5) and biotinyhted anti-c~/~ TCR (H57-597) followed byavidin-PE and then sub- 
jected to analysis by FACStar vlu~ (A). FACS-separated "y/8 TCR + and cx//~ TCIL + T cells (10 ~ cells) were adoptively transferred to SRBC orally toler- 
ized mice and these mice were th n systemically challenged with SR.BC. Splenic anti-SP,.BC of IgM ([2]), IgG1 ([]), IgG2b ([]), and IgA (m) isotypes 
were assessed 4 d later (B). In separate experiments, CD3+ IELs were isolated from SILBC or HR.BC orally primed mice and then adoptively trans- 
ferred to SRBC orally tolerized mice. These mice were systemically im unized with SR.BC, and IgM, IgG1, IgG2b, and IgA responses were assessed 
in an identical manner (B). 
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of OT to anti-SRBC PFC responses (Fig. 2 C). These findings 
provide direct proof that ~//8 TCR + T cells in the 
CD4-,CD8 + and DN IEL subsets possess contrasuppressor 
function. Since the major fraction of 3,/8 TCR + T cells 
resided in the CD4- ,CD8 + T cell subset of IELs, functional 
studies of this subset were performed as described below. 
7/r TCR + IELs Mediate Contrasuppression while cr//~ 
TCR § Cells Exhibit Helper Function. Since 3'/8 TCR + 
IELs from SRBC orally primed mice support antigen-specific 
immune responses in OT, it was important to determine if 
these 3'/6 TCR IELs possess Th cell function. In this regard, 
3'/8 TCR + and a/f l  TCR + IELs, which represent 55% and 
45% of 5.5 x 106 CD3 + [EL T cells (per mouse), were iso- 
lated from orally primed mice and then cultured with purified 
splenic B cells from normal mice in the presence of accessory 
ceils and antigen. As positive controls, CD4 + Th cells were 
isolated from spleens of mice orally primed with SRBC and 
added to identical B cell cultures. The splenic CD4 + ogfl 
TCR + T cells enhanced IgG1 and IgA SRBC-specific im- 
mune responses (Fig. 3). Of interest was the finding that r 
TCR + IELs also provided significant Th cell function for 
IgG subclass and IgA responses. Enriched, r TCR + T 
cells from IELs always upported higher in vitro PFC responses 
than comparable splenic Th cells (Fig. 3). The r TCR § 
IELs and oz/fl TCR + CD4 + splenic T ceils from nonim- 
munized mice did not support any SRBC-specific B cell re- 
sponses. We also assessed the r TCR + T cell subset for 
cytokine production, and this fraction contained a high mes- 
sage for IL-5 in addition to IPN-3' (see Hg. 5 B) and separate 
Northern analysis howed that fuU-length IL-5 mRNA was 
present. Further, the o~/fl TCR + subset contained both 
IFN-'y- and IL-5-producing cells. Independent analysis howed 
that >90% of cells producing these two cytokines produced 
either IPN-3, or IL-5, but not both (manuscript in prepara- 
tion). On the other hand, 3,/8 TCR + IELs that possess con- 
trasuppressor function did not support any SRBC-spedfic 
responses in B ceU cultures (Fig. 3). These results how that 
a /~ TCR + IELs exhibit significant helper functions when 
compared with 3'//~ TCR + IELs (Table 1). 
V. villosa-adherent 7/~ TCR § IELs Contain Both Tcs Cells 
and Low Numbers of lL5-producing Cells. A distinct feature 
of Tcs cells is their high aff~ty for the lectin V. o/I/osa (reviewed 
in reference 40). When CD8 + 3'/8 TCR + IELs were in- 
cubated with biotin-conjugated V. villosa followed by avidin- 
PE, *10-15% of 2.2 x 106 CDS* 3'//~ TCR + IELs (per 
mouse) bound to this lectin (Fig. 4 A). When contrasup- 
pressor function was examined in these two subsets of 3,/8 
TCR § IELs from mice orally primed with SRBC for 3 d, 
the V. villosa-adherent fraction abrogated OT to IgM, IgG1, 
IgG2b, and IgA anti-SRBC PFC responses (Fig. 4 B). On 
the other hand, the V. villosa-nonadherent subset did not 
possess contrasuppressor function. In the next experiment, 
3'/8 TCR + , V. villosa-adherent and -nonadherent T cells 
were isolated from IELs and spleens of mice given SRBC 
for 28 d by the oral route; separate xperiments with mice 
from this group showed that the animals were unresponsive 
to the antigen. Each T cell subset from IELs or spleen of 
Table 1. Unique Characteristics of ~//~ TCR* IELs with 
Helper Function and V. villosa-Adherent "y/~ TCR § IELs 
that Abrogate OT 
T ceUs and rmIL-5 tested (IgA PFC/ 
culture and IL-5 SFC/104 cells) 
Characteristics 3,/8 TCK r TCR rmIL-5 
Abrogate OT* 582 :t: 64 43 _+ 5 36 _+ 12 
Helper function for 
B calls* 26 _+ 7 912 _+ 63 31 _+ 3 
IL-5 productions 45 _+ 7 198 _+ 17 N/A 
* Splenic cells (5 x 106/wall) from SRBC orally tolerized mice were 
cocultured with either 3,/~ TCR + or cx/13 TCR + IELs (5 x 104/weU) 
from mice orally primed with SRBC in the presence ofSRBC. The other 
wells were cocultured with rmlL-5 (5 U/ml) and SRBC. After 5 d of 
incubation, cells were harvested and SRBC-speciiic IgA responses were 
determined by PFC. Spleen cell cultures containing SRBC alone provid- 
ed 35 +_ 9 IgA anti-SRBC PFC. 
Splenic B cells (5.0 • 106/well) from normal mice were cocultured 
with either 3,/8 TCR + or c~//~ TCR + IELs (106/well) from mice orally 
primed with SRBC in the presence ofSRBC. The other wells were cocul- 
tured with rmIL-5 (5 U/ml) and SRBC. After 5 d, IgA responses were 
determined by PI=C as described above. Spleen B cell cultures alone con- 
taining SRBC provided 24 _+ 10 IgA anti-SRBC PFC. 
S ~/8 TCR + and o~/~ TCR + cells were isolated from IELs of SRBC 
orally primed mice by FACS Q and then subjected toIL-S-specific ELISPOT 
assay. 
these mice was then adoptively transferred to syngenic mice 
rendered orally tolerant. Only the 3'/8 TCR +, V. vil- 
Iosa-adherent T cells from IELs abrogated OT (Fig. 4 C). 
On the other hand, 3,/8 TCR+, V. villosa-nonadhe~ent IEL
T cells as well as V. villosa-adherent and -nonadherent splenic 
T cells from the same mice did not convert OT to immune 
responses (Fig. 4 C). These findings showed that 3'/8 
TCR + , V. villosa-adherent T cells in IELs are the only T 
cell fraction that was capable of abrogating OT. Further, this 
would suggest that these 3'/8 TCR + IEL T cells maintain 
appropriate IgA responses at mucosal effector sites in the pres- 
ence of systemic unresponsiveness. 
The frequency of IFN-3,- and Ib5-producing cells were 
also assessed in V. villosa-adherent and -nonadherent 3'/8 
TCR § fractions; large numbers of IFN-3,- or Ib5-producing 
ceils were seen in the latter subset (Fig. 5 A). Further, mRNA 
isolated from "y//~ TCR +, V. villosa-nonadherent fraction 
possessed messages for these two cytokines, most notably for 
Ib5 (Fig. 5 B). On the other hand, the 3'//~ TCR + , V. vil- 
Iosa-adherent fraction contained a lower number of IL-5- 
producing cells (Fig. 5 A). The mRNA-cDNA dot-blot 
hybridization also revealed a low level of IL-5-specific mes- 
sage (Fig. 5 B). In addition, our study showed that exoge- 
nous Ib5 was not suf~cient to reverse antigen-specific un- 
responsiveness in cultures containing spleen cells from OT 
mice (Table 1). 
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Although numbers of cytokine-producing cells are low in 
V. villosa-adherent "g/~ TCR + IELs, a high percentage of 
those cells that produced cytokines were distinguished bytheir 
ability to secrete both IFN-'y and IL-5. Thus, these results 
suggest that 3'//~ TCR +, V. villosa-adherent IELs function 
in antigen-specific immunoregulation, but are not classical 
Th cells (Table 1). Taken together, these results how that 
~/~ TCR+ Tcs ceils possess an affinity for V. villosa, and a 
smaller percentage of these ceils produce cytokines when com- 
pared with the V. villosa-nonadherent fraction. It should also 
be noted that o~//~ TCR + IELs, which contain helper func- 
tion, possess high levels of message for both IL-5 and IFN-3,. 
Thus, we now suggest that IELs contain asubset of T cells 
that provide helper function. 
Discussion 
One unique feature of the mucosal immune system is the 
maintenance ofappropriate IgA responses toorally encoun- 
tered antigens at mucosal surfaces inthe presence of systemic 
unresponsiveness to these antigens, commonly termed OT. 
Thus, oral administration of protein or bacterial antigens 
simultaneously induces antigen-specific OT in systemic sites 
and S-IgA responses in mucosal secretions (41). To protect 
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Figure 2. ~,5 TCR bearing 
CD4-,CD8 + and DN IELs pos- 
sess contrasuppressor function. 
Purified CD3 + IELs, from SRBC 
orally primed mice were incubated 
with biotinylated-anti-CD8 (53.6- 
72) and FI'l'C-anti-,y/6 TCR. (UC7- 
13D5) (,4,/eft) or anti-a/~ TCR 
(H57-597) (/t, right) followed by 
avidin-PE before FAC~ analysis and 
sorting. To obtain DN T cells, IELs 
were incubated with FITC-anti- 
CD3 (145-2Cll) and ARS-con- 
jugated anti-CD4/anti-CD8 fol- 
lowed by PE-anti-ARS and then 
subjected to FACS ~ (B, top). Fur- 
ther, aliquots of DN T cells were 
reacted with biotinylated anti-3,/# 
TCR (B, bottom left) or anti-~x//3 
TCR (B, bottom righ 0 followed by 
avidin tandem. FACS| 
CD4-, CD8 + 3,/(5 TCR + or od~ 
TCR + as well as DN "//8 TCK + 
1ELm (5 x 10 4 calls) were adop- 
tively transferred to SRBC orally 
tolerized mice intravenously, and 
then immunized intraperitoneally 
with SRBC. 4 d later, splenic IgM
([]), IgG1 ([]), IgG2b ([~), and 
IgA (B) anti-SRBC PFC responses 
were enumerated (C). 
IgA responses at mucosal sites such as the lamina propria 
regions of the GI tract, where an environment of suppres- 
sion normally exists, it would be important to determine if 
IELs contain T cells that function i the immune response, 
and in effect maintain this compartment for continued im- 
mune responses to orally encountered antigens. Thus, the 
T cells that reside in the basolateral surfaces of epithelial cells, 
commonly termed IELs, may provide important functions 
in mucosal immune responses. In this study, we tested the 
idea that IELs may possess unique antigen-specific functions 
Figure 3. ~'/~ TCR § contra- 
suppressor IELs do not possess Th 
cell function while od~ TCR + 
IEL fractions provide B cell help. 
FACS~ ~'/~ TCR + or 
od/3 TCR + IELs (106 cells) from 
SRBC orally primed mice were in- 
cubated with purified B cells (5.0 
x 106) and SRBC (2 x 106) for 5 
d. Cells were harvested an IgM 
(I-7), IgG1 (1~), and IgA (11), and 
anti-SRBC PFC responses were x-
amined. As positive controls, splenic 
CD4 + Th cells from spleens of the 
same mice were used. 
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to either support or protect antibody responses at IgA effector 
sites from the influence of systemic unresponsiveness, since 
IELs are continuously exposed to the myriad of antigens from 
the gut lumen. 
The present study has shown that the adoptive transfer 
of CD3 + 3'/~ TCR § T cells from IELs of mice orally im- 
munized with SRBC to recipient mice that are unresponsive 
to this antigen results in the conversion of OT to SRBC- 
specific IgM, IgG1, IgG2b, and IgA responses (Figs. 1 and 
4 C). Further, 3'//~ TCR + T cells in both the CD4- ,CD8 + 
and DN fractions of the IELs possess this contrasuppressor 
function. These findings are the first direct evidence that 
CD3 + ,CD4-,CD8 + , and CD3 + DN T cells, which use the 
7//~ heterodimer chains of the TCK, possess an antigen-specific 
regulatory function. Of further significance was the finding 
that 3,/~ TCK + T cells from IELs can rescue antigen- 
specific antibody responses from the influence of systemic un- 
responsiveness, aneffect hat is especially pronounced for the 
IgA isotype. Further, it is generally considered that CD4 + 
Th cells in the underlying lamina propria regions induce the 
terminal differentiation f B cells into IgA-produdng plasma 
cells. In this regard, our recent studies have shown that high 
numbers of Th2-type CD4 + T cells, which produce key 
cytokines uch as Ib5 and Ib6 for terminal differentiation 
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Figure 4. V. v///osa (V.g)-adhermt 
3'/8 TCR + IELs possess contra- 
suppressor fttnction. Purified CD8 + 
T cells from IELs of mice orally 
primed with SRBC were stained 
with FITC-anti-3,/8 TCK (UC7- 
13D5) and biotinylated anti-V.t~ fol- 
lowed by avidin-PE and then sub- 
jected to FACS | analysis (A). 
FACS~ V.v.-adherent and 
-nonadherent CD8 + 3'/8 TCR + 
IELs (5 x 10 4) from mice orally 
primed with SRBC for 3 d were 
adoptively transferred to mice orally 
tolerized with, and then immunized 
with, SRBC. 4 d later, splenic IgM 
(D), IgG1 (l~), IgG2b ([]), and 
IgA (l l) anti-SRBC PF'C responses 
were enumerated (/3). Flow cytom- 
etry isolated, V.v.-adherent and 
-nonadherent y/8 TCR + T cells (5 
x 104) from IEL and spleen of 
mice orally immunized with SRBC 
for 28 d were adoptively transferred 
to mice rendered tolerant to SKBC. 
These mice were then immunized 
with SRBC. 4 d later, splenic IgM 
([2]), IgG1 (~), IgG2b ([]), and 
Ig, A (l l) anti-SRBC PPC responses 
were determined (C). 
of surface IgA § (sIgA +) B cells to become high Ig- 
producing cells, are seen in lamina propria regions when com- 
pared with other tissues (23, 31, 42). However, a subset of 
3'/8 TCR + IELs do not serve as Th cells for antibody re- 
sponses, but serve as an enhancing cell type that can over- 
come immunologic tolerance (Table 1). Taken together, the 
anatomical proximity of CD8 + and DN Tcs ceils and CD4 + 
Th cells at IgA effector sites would make physiological sense, 
since this would provide maintenance of efficient IgA responses 
for the protection of mucosal surfaces. Further, it is also pos- 
sible that 3,/8 TCK + Tcs cells in the IELs could also en- 
hance (or protect) cytotoxic T cells from the influence of sup- 
pression, since it has been shown that a subset of IELs in 
human jejunum and colon do not express the cytotoxic 
ceil-specific surface ntigen H366 and exhibit suppressor func- 
tion (43). However, this point remains to be established and 
will be addressed in future studies. 
To further characterize 3'/8 TCR-bearing Tcs ceils in IELs, 
"y/8 TCR + T cells from SRBC orally primed mice were 
separated into V. villosa-adherent and -nonadherent fractions, 
since it has been shown that a unique feature of Tcs calls is 
a strong affinity for this plant lectin (40). When these two 
fractions of "y/8 TCR + IELs were adoptively transferred to
mice with OT, only the V. villosa-adherent ceils abrogated 
OT to SRBC-specific immune responses (Fig. 4 B). This re- 
sult provided further evidence that 3'/8 TCK + IELs, which 
share with Tcs cells the property of binding to V. villosa, can 
mediate contrasuppression. Furthermore, the ~,/8 TCR + Tcs 
cells were also observed in the V. villosa-adherent fraction 
of mice rendered orally tolerant o SRBC (Fig. 4 C). This 
would suggest that these cells are indeed functioning in the 
epithelium of mice that are receiving toleragenic doses of an- 
tigen. Further, this subset of CD3 + T cells in IELs may play 
an important role in the maintenance of IgA responses in 
the presence of suppression i the gut. 
This characteristic of V. villosa binding was also important 
since it allowed us to separate functional Tcs cells from IELs 
that differed in cytokine production. Thus, when cytokine 
secretion and mKNA levels (e.g., IFN-3, and II~5) by 3'/8 
TCR + , V. villosa-adherent and -nonadherent cells were ex- 
amined, the V. villosa-adherent fraction with contrasuppressor 
function exhibited low IL-5 levels (Fig. 5). On the other hand, 
the V. villosa-nonadherent fraction contained higher numbers 
of IL-5- (and IFN-'y)-producing cells. This finding does not 
support he idea that Tcs cells are a form of Th cells or "super" 
Th ceils, since 3'/8 TCK + , V. villosa-adherent Tcs cells in 
IELs do not produce IL-5. On the contrary, Th2 type cells 
in IgA effector tissues (e.g., the lamina propria region of in- 
testine) secrete significant amounts of II.-5 (24). Further, by 
use of Th cell assays, the 3'/8 TCK + IELs from SRBC- 
primed mice did not support antigen-specific PFC responses, 
while ot/fl TCR + IELs and splenic CD4 + Th cells from the 
same mice enhanced both IgG and IgA anti-SRBC responses 
(Fig. 3). In fact, the ol/fl TCR + IELs supported IgG and 
IgA responses that exceeded those seen with splenic CD4 + 
Th cells (Table 1 and Fig. 3). These findings have provided 
important new evidence that o~/B TCK + IELs are capable 
of providing helper function, while 3'/8 TCR + IELs con- 
tain subsets capable of abrogating oral tolerance (e.g., con- 
trasuppression). 
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Figure 5. E v/I/osa (V.v)-adherent 
7/8 TCR + IELs contain low levels 
of I1.-5 message while odl3 TCR + 
IELs possess high Ib-5 expression. 
Purified CD8 § T cells from IELs 
of SRBC orally primed mice were 
stained with FITC-anti-7/8 TCR 
(UC7-13DS) and biotinylated anti- 
V.v. followed by avidin-PE and then 
subjected toFACS ~ analysis ( ee Fig. 
4 A). FACS| V.v.-adher- 
ent and -nonadherent CD8 + 71,/8 
TCR + IELs were subjected to
IFN-7- and IL-5-specific ELISPOT 
assay (.-4). Extracted mRNA from 
individual subsets of IELs including 
od/~ TCR § T cells and V.v.- 
adherent and -nonadherent CD8 + 
7/8 TCR + T cells were hybridized 
with IFN-3,- and IL-5-specific 
cDNA probes (B). As positive con- 
trols, mRNA from Con A-stimu- 
lated splenic T cells or IL-5-trans- 
fected X63-Ag8-653X5 were used. 
mRNA extracted from freshly iso- 
lated thymocytes andnonstimulated 
splenic T cells were used as nega- 
tive controls. Levels of hybridization 
were examined by scanning and ex- 
pressed as relative gray scale (score 
of 0-200). The quality of mRNA 
was verified by use of an actin- 
specific DNA probe. 
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As indicated above, it was significant hat 3'/6 TCK + ,
V. villosa-adherent Tcs cells in IELs contained low numbers 
of cytokine producing cells. Further, of the V. v/I/osa-adherent 
cells that were secreting IFN-3, and II.,5, at least 50% were 
shown to produce both cytokines imultaneously (double 
cytokine producers) (Fig. 5 A). This feature is dearly dis- 
tinct from classical Th cell clones, which can be separated 
into IFN-3, producing Thl-type and Ib5 secreting Th2-type 
cells (44). Taken together, these results have also provided 
compelling evidence that 3,/~5 TCR + IELs with contrasup- 
pressor function are not a form of Th cells. In this regard, 
our previous tudies have also shown that CD3 + DN Tcs 
cells isolated from spleens of mice orally primed with SRBC 
are distinct from classical Th cells (20). It should be empha- 
sized that only small numbers (as few as 5 x 104 T cells) 
of Tcs cells are required for abrogation of OT upon adoptive 
transfer. On the other hand, adoptive transfer of Th calls into 
nude mice have shown that 5 x 10 ~ to 5 x 107 T cells are 
required for T-dependent responses to SRBC (manuscript in 
preparation). Thus, we can now conclude that Tcs cells do 
not function as Th cells both in vitro and in vivo (Table 1). 
The finding of low numbers of cytokine producing cells 
in q,/~ TCK +, V. villosa-adherent T cells in IELs has raised 
another important issue, since it has been shown that CD4 + 
T cells from murine PP, an important IgA inductive tissue, 
can be separated into two subsets based upon their ability 
to bind V. villosa (45). In this study, IL-5 production was only 
seen in the V. villosa-adherent fraction, but not in the V. vil- 
losa-nonadherent fraction (45). In contrast, our present study 
has shown that V. villosa-adherent Tcs cells in IELs produced 
little Ib5. Further, it was suggested that these V. villosa- 
adherent 3'//~ TCK + cells were of major importance in con- 
trasuppression. Our studies have also provided evidence that 
these cytokines cannot break tolerance since addition of an 
optimal concentration of rib5 to cultures containing spleno- 
cytes from SRBC orally tolerized mice and homologous an- 
tigen did not support IgA anti-SRBC responses (Table 1). 
Although we cannot yet explain the discrepancy between these 
two studies, the most likely explanation i volves the major 
differences in TCK usage and in CD8 expression between 
these two subsets (CD8 + 3'/# TCK + IEL T cells vs. CD4 ~ 
ov'B TCK + PP T cells), both of which exhibit an affinity 
for V. villosa lectin. Further, it is also possible that the tissue 
environment (e.g., IgA effector [IELs] vs. inductive [PP]) sites 
may result in T cell subsets (with different functions) that 
possess different affinity for this lectin. 
It will be important o next determine the precise mecha- 
nism for the abrogation of OT by ",//~ TCR + IEL T cells. 
These 3'/~ TCR + Tcs cells are not active cytokine (e.g., 
IFN-3, and IL-5)-producing cells. Thus, q,//~ TCR § Tcs cells 
may require direct cell-to-cell contact with CD4 + Th calls 
in order to provide their contrasuppressor function. In this 
regard, it is possible that 3'/# TCR + T cells may recognize 
the TCK idiotype expressed by the V regions of ce/3 TCK 
on CD4 + Th cells. 3'/~ TCR+ IELs may also interact with 
CD4 + Th cells via the CD1 molecule since it has been 
shown that 3'//~ T cells isolated from immunodeficient pa- 
tients recognized aCD1 + target T cell line (46, 47). Alter- 
natively, 3'/~ TCK § IELs may communicate with ~/3  
TCR + CD4 § T cells via a heat shock protein-like molecule 
expressed on activated latter cells. Further, it is possible that 
CD8 + 3'//~ TCR + T cells may interact with antigen- 
presenting cells, including B cells in an MHC class II-re- 
stricted manner, since a recent study has provided evidence 
that CD8 + 3,/~ TCK + T cells in IELs exhibit MHC class 
II-restricted antigen recognition (48). Thus, the selection of 
a certain family of V'y genes (V3'4) was always associated 
with a distinct haplotype of I-E expression (48). Moreover, 
it has been shown that antigen-specific "y//~ TCR + T cells 
can respond to tetanus toxoid antigen in a class II-restricted 
manner (49). Although the present study has provided anew 
and novel feature of y /6 TCR + Tcs cells in IELs, the exact 
mechanisms for the abrogation of OT by this subset of regula- 
tory T cells remains to be elucidated. 
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